Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001732524-18-000001
Filing Date
2018-02-23
Accepted
2018-02-23 08:45:27
Documents
1
Effectiveness Date
2018-02-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5614
  Complete submission text file 0001732524-18-000001.txt   6686
Mailing Address ONE KENDALL SQUARE BUILDING 200 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200 CAMBRIDGE MA 02139 301-204-6781
Panther Pharmaceuticals, Inc. (Filer) CIK: 0001732524 (see all company filings)

EIN.: 823072987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-306279 | Film No.: 18634732